LabMD appeal would challenge FTC data security injury, causations standards

16 Aug LabMD appeal would challenge FTC data security injury, causations standards

U.S. Federal Trade Commission building.  October 16, 2012.  Photo by Diego M. Radzinschi/THE NATIONAL LAW JOURNAL.

U.S. Federal Trade Commission building. October 16, 2012. Photo by Diego M. Radzinschi/THE NATIONAL LAW JOURNAL.

Medical testing company LabMD Inc. will likely appeal the Federal Trade Commission’s recent decision reasserting its authority to take data security enforcement action against companies.

In that ruling, the FTC held that to demonstrate unfairness to consumers under Section 5 of the FTC Act its enforcement staff needn’t demonstrate specific harm to consumers from a data breach in order to take action against a company. Allegedly lax data security leading to a breach is enough on its own without more to show unfair business practices, the commission held.

That conclusion has significant implications for companies considering the risk of enforcement action by the FTC. It may also influence other legal proceedings where the inability of plaintiffs to demonstrate harm resulting from a data breach of their personal information has been a leading reason for dismissal of their actions.

Read the full article below:

Bloomberg BNA – LabMD Appeal Story

Michael Daugherty
mdort@aol.com

Michael Daugherty is President & CEO of LabMD, an Atlanta-based clinical and anatomic medical laboratory with a national client base. Mike founded LabMD in 1996 after 14 years in surgical device sales with U.S. Surgical Corp. and Mentor Corporation. Outside of LabMD, enjoys playing tennis, travel, and flying his Cirrus SR22 Turbo single engine aircraft.